loading
前日終値:
$459.62
開ける:
$460
24時間の取引高:
923.20K
Relative Volume:
0.56
時価総額:
$115.95B
収益:
$11.10B
当期純損益:
$-988.90M
株価収益率:
-116.94
EPS:
-3.92
ネットキャッシュフロー:
$-1.26B
1週間 パフォーマンス:
+2.94%
1か月 パフォーマンス:
+1.72%
6か月 パフォーマンス:
+12.23%
1年 パフォーマンス:
-3.43%
1日の値動き範囲:
Value
$455.79
$461.25
1週間の範囲:
Value
$443.49
$461.25
52週間の値動き範囲:
Value
$377.85
$519.88

Vertex Pharmaceuticals Inc Stock (VRTX) Company Profile

Name
名前
Vertex Pharmaceuticals Inc
Name
セクター
Healthcare (1165)
Name
電話
(617) 341-6393
Name
住所
50 NORTHERN AVENUE, BOSTON, MA
Name
職員
6,100
Name
Twitter
@VertexPharma
Name
次回の収益日
2025-02-10
Name
最新のSEC提出書
Name
VRTX's Discussions on Twitter

VRTX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.97 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
536.34 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
324.19 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.68 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
241.39 28.51B 3.81B -644.79M -669.77M -6.24

Vertex Pharmaceuticals Inc Stock (VRTX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-05-07 ダウングレード Wolfe Research Outperform → Peer Perform
2025-05-06 ダウングレード Leerink Partners Outperform → Market Perform
2025-04-22 再開されました Cantor Fitzgerald Overweight
2025-02-12 アップグレード Canaccord Genuity Sell → Hold
2025-02-11 アップグレード Canaccord Genuity Sell → Hold
2025-01-30 ダウングレード Wells Fargo Overweight → Equal Weight
2024-12-20 繰り返されました H.C. Wainwright Buy
2024-12-19 ダウングレード Oppenheimer Outperform → Perform
2024-12-09 アップグレード Jefferies Hold → Buy
2024-11-14 開始されました Citigroup Buy
2024-10-16 開始されました Scotiabank Sector Perform
2024-10-10 再開されました Raymond James Mkt Perform
2024-08-05 ダウングレード Barclays Overweight → Equal Weight
2024-06-27 開始されました Redburn Atlantic Buy
2024-04-11 アップグレード Evercore ISI In-line → Outperform
2024-02-15 開始されました Wolfe Research Outperform
2024-02-06 ダウングレード Evercore ISI Outperform → In-line
2024-02-02 ダウングレード Bernstein Outperform → Mkt Perform
2024-01-31 ダウングレード Maxim Group Buy → Hold
2024-01-31 ダウングレード Robert W. Baird Neutral → Underperform
2024-01-24 ダウングレード Canaccord Genuity Hold → Sell
2023-12-14 繰り返されました RBC Capital Mkts Sector Perform
2023-05-30 開始されました William Blair Outperform
2023-05-04 再開されました Piper Sandler Overweight
2023-03-21 開始されました Bernstein Outperform
2023-01-18 開始されました Canaccord Genuity Hold
2023-01-17 アップグレード SVB Leerink Mkt Perform → Outperform
2022-12-19 ダウングレード Jefferies Buy → Hold
2022-07-13 開始されました Cantor Fitzgerald Overweight
2022-06-01 アップグレード Maxim Group Hold → Buy
2022-05-23 開始されました SVB Leerink Mkt Perform
2022-05-06 ダウングレード Robert W. Baird Outperform → Neutral
2022-05-03 アップグレード Morgan Stanley Underweight → Equal-Weight
2022-02-03 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2022-01-27 繰り返されました JP Morgan Overweight
2022-01-27 繰り返されました Morgan Stanley Underweight
2022-01-27 繰り返されました RBC Capital Mkts Outperform
2022-01-27 繰り返されました Stifel Hold
2022-01-27 繰り返されました Wolfe Research Outperform
2022-01-20 アップグレード BMO Capital Markets Market Perform → Outperform
2021-12-09 開始されました Wells Fargo Overweight
2021-11-19 開始されました BMO Capital Markets Market Perform
2021-11-19 ダウングレード Piper Sandler Overweight → Neutral
2021-09-09 ダウングレード Stifel Buy → Hold
2021-09-07 ダウングレード Morgan Stanley Equal-Weight → Underweight
2021-07-20 ダウングレード SVB Leerink Mkt Perform → Underperform
2021-07-19 再開されました Wolfe Research Outperform
2021-07-01 開始されました Raymond James Mkt Perform
2021-06-11 ダウングレード Daiwa Securities Outperform → Neutral
2021-02-23 アップグレード Robert W. Baird Neutral → Outperform
2021-02-02 繰り返されました H.C. Wainwright Buy
2020-12-30 開始されました Daiwa Securities Outperform
2020-11-30 アップグレード RBC Capital Mkts Sector Perform → Outperform
2020-11-20 開始されました Bernstein Outperform
2020-10-28 開始されました UBS Buy
2020-07-31 繰り返されました H.C. Wainwright Buy
2020-07-08 ダウングレード Morgan Stanley Overweight → Equal-Weight
2020-04-30 繰り返されました H.C. Wainwright Buy
2020-04-28 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2020-03-04 開始されました Barclays Overweight
2020-01-31 ダウングレード Robert W. Baird Outperform → Neutral
2019-11-19 アップグレード Guggenheim Neutral → Buy
2019-11-12 開始されました SunTrust Buy
2019-10-17 再開されました BofA/Merrill Buy
2019-09-03 アップグレード Goldman Neutral → Buy
2019-08-01 ダウングレード Needham Buy → Hold
2019-05-23 再開されました Citigroup Buy
2019-05-21 開始されました Credit Suisse Outperform
2019-04-12 開始されました Evercore ISI In-line
2019-03-26 アップグレード William Blair Mkt Perform → Outperform
2019-03-19 ダウングレード SVB Leerink Outperform → Mkt Perform
2019-02-06 ダウングレード Maxim Group Buy → Hold
すべてを表示

Vertex Pharmaceuticals Inc (VRTX) 最新ニュース

pulisher
Jun 18, 2025

10 Biotech Stocks Screaming a Buy - Insider Monkey

Jun 18, 2025
pulisher
Jun 18, 2025

Vertex Pharmaceuticals (VRTX) Soared as Investors Back Strategic Initiatives - Insider Monkey

Jun 18, 2025
pulisher
Jun 18, 2025

RBC Capital Sticks to Their Hold Rating for Vertex Pharmaceuticals (VRTX) - The Globe and Mail

Jun 18, 2025
pulisher
Jun 17, 2025

Vertex Pharmaceuticals (VRTX) Price Target Slightly Reduced by R - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

A Glimpse Into The Expert Outlook On Vertex Pharmaceuticals Through 10 Analysts - Nasdaq

Jun 17, 2025
pulisher
Jun 17, 2025

Vertex Pharmaceuticals price target lowered to $420 from $423 at RBC Capital - TipRanks

Jun 17, 2025
pulisher
Jun 17, 2025

Vertex Pharmaceuticals (VRTX) Price Target Lowered Amid Concerns - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Vertex Pharmaceuticals (VRTX) Price Target Lowered Amid Concerns | VRTX Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

RBC Capital Adjusts PT on Vertex Pharmaceuticals to $420 From $423, Maintains Sector Perform Rating - MarketScreener

Jun 17, 2025
pulisher
Jun 16, 2025

Saudia Arabia Introduces Strategic Healthcare Vision and Global Partnerships at BIO 2025 - GlobeNewswire Inc.

Jun 16, 2025
pulisher
Jun 16, 2025

Aries Wealth Management Buys New Shares in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat

Jun 16, 2025
pulisher
Jun 16, 2025

Everhart Financial Group Inc. Buys 553 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat

Jun 16, 2025
pulisher
Jun 16, 2025

CCM Investment Advisers LLC Acquires 5,351 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat

Jun 16, 2025
pulisher
Jun 16, 2025

Opinicus Capital Inc. Invests $397,000 in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat

Jun 16, 2025
pulisher
Jun 16, 2025

Ferguson Wellman Capital Management Inc. Takes $391,000 Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat

Jun 16, 2025
pulisher
Jun 15, 2025

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Acquired by RMR Wealth Builders - MarketBeat

Jun 15, 2025
pulisher
Jun 15, 2025

Integrated Advisors Network LLC Has $1.05 Million Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat

Jun 15, 2025
pulisher
Jun 15, 2025

Optas LLC Has $864,000 Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat

Jun 15, 2025
pulisher
Jun 15, 2025

Brighton Jones LLC Purchases 1,994 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat

Jun 15, 2025
pulisher
Jun 15, 2025

Foster Victor Wealth Advisors LLC Sells 1,664 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat

Jun 15, 2025
pulisher
Jun 15, 2025

Massachusetts Wealth Management Makes New Investment in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat

Jun 15, 2025
pulisher
Jun 15, 2025

Yousif Capital Management LLC Sells 664 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat

Jun 15, 2025
pulisher
Jun 15, 2025

Simplicity Wealth LLC Has $630,000 Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat

Jun 15, 2025
pulisher
Jun 15, 2025

Redhawk Wealth Advisors Inc. Cuts Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat

Jun 15, 2025
pulisher
Jun 14, 2025

Vertex Pharmaceuticals’ SWOT analysis: stock poised for growth amid pipeline expansion - Investing.com

Jun 14, 2025
pulisher
Jun 14, 2025

Compagnie Lombard Odier SCmA Raises Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat

Jun 14, 2025
pulisher
Jun 14, 2025

Simon Quick Advisors LLC Has $1.42 Million Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat

Jun 14, 2025
pulisher
Jun 14, 2025

SG Americas Securities LLC Purchases 17,502 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat

Jun 14, 2025
pulisher
Jun 14, 2025

Greenwood Capital Associates LLC Sells 6,572 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat

Jun 14, 2025
pulisher
Jun 14, 2025

Stanley Laman Group Ltd. Buys New Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat

Jun 14, 2025
pulisher
Jun 14, 2025

UMB Bank n.a. Sells 1,666 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat

Jun 14, 2025
pulisher
Jun 14, 2025

Vertex Pharma announces new share buybacks worth up to $4B - MSN

Jun 14, 2025
pulisher
Jun 13, 2025

Vertex Pharmaceuticals (VRTX) Stock Moves -1.00%: What You Should Know - Yahoo Finance

Jun 13, 2025
pulisher
Jun 13, 2025

Vertex Pharmaceuticals Stock Outlook: Is Wall Street Bullish or Bearish? - MSN

Jun 13, 2025
pulisher
Jun 13, 2025

Handelsbanken Fonder AB Trims Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat

Jun 13, 2025
pulisher
Jun 12, 2025

Healey boosts life sciences tax incentives as 33 companies plan major expansions - The Business Journals

Jun 12, 2025
pulisher
Jun 12, 2025

Boston drug company laying off 125 employees in R.I. - Boston.com

Jun 12, 2025
pulisher
Jun 12, 2025

Boston probes misconduct claims against city official - Axios

Jun 12, 2025
pulisher
Jun 12, 2025

Portside Wealth Group LLC Has $1.43 Million Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat

Jun 12, 2025
pulisher
Jun 11, 2025

Vertex Presents New Data on the Benefits of ALYFTREK - Insider Monkey

Jun 11, 2025
pulisher
Jun 11, 2025

Vertex Pharmaceuticals lays off 125 workers in RI - WPRI.com

Jun 11, 2025
pulisher
Jun 11, 2025

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Stake Lifted by Wedmont Private Capital - MarketBeat

Jun 11, 2025
pulisher
Jun 11, 2025

Boston drugmaker Vertex slashes Providence workforce, shrinks real estate following trial failure - The Business Journals

Jun 11, 2025
pulisher
Jun 11, 2025

SeaCrest Wealth Management LLC Purchases New Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - MarketBeat

Jun 11, 2025
pulisher
Jun 11, 2025

Vertex to lay off 125 employees in R.I., consolidate offices - The Boston Globe

Jun 11, 2025
pulisher
Jun 11, 2025

Vertex lays off 125 staffers, slims Rhode Island campus after ditching failed diabetes cell-device combo - Fierce Biotech

Jun 11, 2025
pulisher
Jun 11, 2025

Vertex lays off 125 staffers after halting work on diabetes 'cells plus device' therapy - FirstWord Pharma

Jun 11, 2025
pulisher
Jun 11, 2025

After axing diabetes asset, Vertex lays off 140 staff - PharmaLive

Jun 11, 2025
pulisher
Jun 11, 2025

After Axing Diabetes Asset, Vertex Lays Off 140 Staff - BioSpace

Jun 11, 2025
pulisher
Jun 11, 2025

Five things: The Newbury GM, Zoominfo cuts, Vertex, Boston Scientific and casino night - The Business Journals

Jun 11, 2025
pulisher
Jun 11, 2025

How Is Vertex Pharmaceuticals’ Stock Performance Compared to Other Biotech Stocks? - MSN

Jun 11, 2025

Vertex Pharmaceuticals Inc (VRTX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$545.87
price up icon 0.27%
$321.23
price down icon 1.79%
$540.73
price down icon 0.34%
biotechnology ONC
$242.65
price down icon 0.20%
$110.60
price up icon 0.50%
大文字化:     |  ボリューム (24 時間):